OBLN - OBALON THERAPEUTICS INC
Form 424B4 Period: OCT.06.16 Date Filed: OCT.06.16
Transcript Split
  
  
     
Move to First Section Move to Last Section
INDEX
Page-by-Page
  Form 424B4 (Entire Filing)

Filing Body

Page 1: Filed pursuant to Rule 424(b)(4)

Page 2: TABLE OF CONTENTS

Page 3: This summary highlights selected information contained elsewhere in this prospectus and does not con

Page 4: THE OBESITY EPIDEMIC

Page 5: OUR STRATEGY

Page 6: THE OBALON BALLOON SYSTEM

Page 7: RISK FACTORS

Page 8: IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY

Page 9: N/A

Page 10: N/A

Page 11: N/A

Page 12: SUMMARY CONSOLIDATED FINANCIAL DATA

Page 13: N/A

Page 14: Investing in our common stock involves a high degree of risk. Before making your decision to invest

Page 15: Risk factors

Page 16: Risk factors

Page 17: Risk factors

Page 18: Risk factors

Page 19: Risk factors

Page 20: Risk factors

Page 21: Risk factors

Page 22: We may not be able to secure additional financing on favorable terms, or at all, to meet our future

Page 23: Risk factors

Page 24: Risk factors

Page 25: Risk factors

Page 26: Risk factors

Page 27: Risk factors

Page 28: Risk factors

Page 29: Risk factors

Page 30: Risk factors

Page 31: Risk factors

Page 32: Risk factors

Page 33: Risk factors

Page 34: Risk factors

Page 35: Risk factors

Page 36: Risk factors

Page 37: Risk factors

Page 38: Risk factors

Page 39: Risk factors

Page 40: Risk factors

Page 41: Risk factors

Page 42: Risk factors

Page 43: Risk factors

Page 44: Risk factors

Page 45: Risk factors

Page 46: Risk factors

Page 47: Risk factors

Page 48: Risk factors

Page 49: Risk factors

Page 50: Risk factors

Page 51: Risk factors

Page 52: Risk factors

Page 53: Risk factors

Page 54: Risk factors

Page 55: Risk factors

Page 56: Risk factors

Page 57: Risk factors

Page 58: N/A

Page 59: N/A

Page 60: N/A

Page 61: N/A

Page 62: Capitalization

Page 63: N/A

Page 64: Dilution

Page 65: Dilution

Page 66: N/A

Page 67: Selected consolidated financial data

Page 68: Selected consolidated financial data

Page 69: You should read the following discussion and analysis of our financial condition and results of oper

Page 70: Management s discussion and analysis of financial condition and results of operations

Page 71: Management s discussion and analysis of financial condition and results of operations

Page 72: Management s discussion and analysis of financial condition and results of operations

Page 73: Management s discussion and analysis of financial condition and results of operations

Page 74: Management s discussion and analysis of financial condition and results of operations

Page 75: Management s discussion and analysis of financial condition and results of operations

Page 76: Management s discussion and analysis of financial condition and results of operations

Page 77: Management s discussion and analysis of financial condition and results of operations

Page 78: Management s discussion and analysis of financial condition and results of operations

Page 79: Management s discussion and analysis of financial condition and results of operations

Page 80: Management s discussion and analysis of financial condition and results of operations

Page 81: Management s discussion and analysis of financial condition and results of operations

Page 82: Management s discussion and analysis of financial condition and results of operations

Page 83: Management s discussion and analysis of financial condition and results of operations

Page 84: OVERVIEW

Page 85: Business

Page 86: Business

Page 87: Business

Page 88: Business

Page 89: Business

Page 90: Business

Page 91: Business

Page 92: Business

Page 93: Business

Page 94: Business

Page 95: Business

Page 96: Business

Page 97: Business

Page 98: Business

Page 99: Business

Page 100: Business

Page 101: Business

Page 102: Business

Page 103: Business

Page 104: Business

Page 105: Business

Page 106: Business

Page 107: Business

Page 108: Business

Page 109: Business

Page 110: Business

Page 111: Business

Page 112: Business

Page 113: Business

Page 114: Business

Page 115: EXECUTIVE OFFICERS AND DIRECTORS

Page 116: Management

Page 117: Management

Page 118: Management

Page 119: Management

Page 120: Management

Page 121: Management

Page 122: Management

Page 123: Management

Page 124: SUMMARY COMPENSATION TABLE

Page 125: Executive compensation

Page 126: Executive compensation

Page 127: Executive compensation

Page 128: Executive compensation

Page 129: Executive compensation

Page 130: Executive compensation

Page 131: Executive compensation

Page 132: Executive compensation

Page 133: Executive compensation

Page 134: EQUITY FINANCINGS

Page 135: Certain relationships and related-party transactions

Page 136: Certain relationships and related-party transactions

Page 137: N/A

Page 138: Principal stockholders

Page 139: Principal stockholders

Page 140: COMMON STOCK

Page 141: Description of capital stock

Page 142: Description of capital stock

Page 143: Description of capital stock

Page 144: Description of capital stock

Page 145: Description of capital stock

Page 146: Description of capital stock

Page 147: LOCK-UP AGREEMENTS

Page 148: Shares eligible for future sale

Page 149: Shares eligible for future sale

Page 150: N/A

Page 151: Material U.S. federal income tax consequences to non-U.S. holders of common stock

Page 152: Material U.S. federal income tax consequences to non-U.S. holders of common stock

Page 153: Material U.S. federal income tax consequences to non-U.S. holders of common stock

Page 154: Material U.S. federal income tax consequences to non-U.S. holders of common stock

Page 155: Material U.S. federal income tax consequences to non-U.S. holders of common stock

Page 156: OPTION TO PURCHASE ADDITIONAL SHARES

Page 157: Underwriting

Page 158: Underwriting

Page 159: Underwriting

Page 160: Underwriting

Page 161: Underwriting

Page 162: Underwriting

Page 163: Underwriting

Page 164: Underwriting

Page 165: N/A

Page 166: N/A

Page 167: F-1

Page 168: F-2

Page 169: OBALON THERAPEUTICS, INC.

Page 170: OBALON THERAPEUTICS, INC.

Page 171: OBALON THERAPEUTICS, INC.

Page 172: OBALON THERAPEUTICS, INC.

Page 173: OBALON THERAPEUTICS, INC.

Page 174: OBALON THERAPEUTICS, INC.

Page 175: OBALON THERAPEUTICS, INC.

Page 176: OBALON THERAPEUTICS, INC.

Page 177: OBALON THERAPEUTICS, INC.

Page 178: OBALON THERAPEUTICS, INC.

Page 179: OBALON THERAPEUTICS, INC.

Page 180: OBALON THERAPEUTICS, INC.

Page 181: OBALON THERAPEUTICS, INC.

Page 182: OBALON THERAPEUTICS, INC.

Page 183: OBALON THERAPEUTICS, INC.

Page 184: OBALON THERAPEUTICS, INC.

Page 185: OBALON THERAPEUTICS, INC.

Page 186: OBALON THERAPEUTICS, INC.

Page 187: OBALON THERAPEUTICS, INC.

Page 188: OBALON THERAPEUTICS, INC.

Page 189: OBALON THERAPEUTICS, INC.

Page 190: OBALON THERAPEUTICS, INC.

Page 191: OBALON THERAPEUTICS, INC.

Page 192: OBALON THERAPEUTICS, INC.

Page 193: OBALON THERAPEUTICS, INC.

Page 194: OBALON THERAPEUTICS, INC.

Page 195: OBALON THERAPEUTICS, INC.

Page 196: OBALON THERAPEUTICS, INC.

Page 197: OBALON THERAPEUTICS, INC.

Page 198: OBALON THERAPEUTICS, INC.

Page 199: OBALON THERAPEUTICS, INC.

Page 200: OBALON THERAPEUTICS, INC.

Page 201: OBALON THERAPEUTICS, INC.

Page 202: OBALON THERAPEUTICS, INC.

Page 203: OBALON THERAPEUTICS, INC.

Page 204: OBALON THERAPEUTICS, INC.

Page 205: OBALON THERAPEUTICS, INC.

Page 206: OBALON THERAPEUTICS, INC.

Page 207: OBALON THERAPEUTICS, INC.

Page 208: OBALON THERAPEUTICS, INC.

Page 209: OBALON THERAPEUTICS, INC.

Page 210: OBALON THERAPEUTICS, INC.

Page 211: OBALON THERAPEUTICS, INC.

Page 212: OBALON THERAPEUTICS, INC.

Page 213: OBALON THERAPEUTICS, INC.

Page 214: OBALON THERAPEUTICS, INC.

Page 215: OBALON THERAPEUTICS, INC.

Page 216: OBALON THERAPEUTICS, INC.

Page 217: Through and including October 30, 2016 (the 25th day after the date of this prospectus), all dealers

   CURRENT PAGE
    Download Current Page as a Word Document  Download Current Page as a PDF Document    Download Excel File of Financials